These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26149376)

  • 21. A Novel NIPBL-NACC1 Gene Fusion Is Characteristic of the Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma.
    Argani P; Palsgrove DN; Anders RA; Smith SC; Saoud C; Kwon R; Voltaggio L; Assarzadegan N; Oshima K; Rooper L; Matoso A; Zhang L; Cantarel BL; Gagan J; Antonescu CR
    Am J Surg Pathol; 2021 Nov; 45(11):1550-1560. PubMed ID: 33999553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.
    Arnold A; Bahra M; Lenze D; Bradtmöller M; Guse K; Gehlhaar C; Bläker H; Heppner FL; Koch A
    Exp Mol Pathol; 2015 Oct; 99(2):344-53. PubMed ID: 26260902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 Mutations in human cholangiocarcinoma: a review.
    Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD
    Liver Int; 2005 Aug; 25(4):704-16. PubMed ID: 15998419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis: A better FISH to detect pancreatobiliary cancer?
    Patman G
    Nat Rev Gastroenterol Hepatol; 2015 Oct; 12(10):551. PubMed ID: 26369313
    [No Abstract]   [Full Text] [Related]  

  • 25. Mutational landscape of intrahepatic cholangiocarcinoma.
    Zou S; Li J; Zhou H; Frech C; Jiang X; Chu JS; Zhao X; Li Y; Li Q; Wang H; Hu J; Kong G; Wu M; Ding C; Chen N; Hu H
    Nat Commun; 2014 Dec; 5():5696. PubMed ID: 25526346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting the genetic susceptibility for cholangiocarcinoma in primary sclerosing cholangitis.
    Lazaridis KN
    Hepatology; 2008 Jan; 47(1):8-10. PubMed ID: 18161699
    [No Abstract]   [Full Text] [Related]  

  • 27. MicroRNAs in the biology and diagnosis of cholangiocarcinoma.
    Piontek K; Selaru FM
    Semin Liver Dis; 2015 Feb; 35(1):55-62. PubMed ID: 25632935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IDH Mutation Subgroup Status Associates with Intratumor Heterogeneity and the Tumor Microenvironment in Intrahepatic Cholangiocarcinoma.
    Xiang X; Liu Z; Zhang C; Li Z; Gao J; Zhang C; Cao Q; Cheng J; Liu H; Chen D; Cheng Q; Zhang N; Xue R; Bai F; Zhu J
    Adv Sci (Weinh); 2021 Sep; 8(17):e2101230. PubMed ID: 34250753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial: Cholangiocarcinoma - a rare and devastating, but no longer forsaken tumor.
    Housset C
    Curr Opin Gastroenterol; 2020 Mar; 36(2):55-56. PubMed ID: 31895233
    [No Abstract]   [Full Text] [Related]  

  • 30. [Expression of melanoma antigen-1, 3 genes in human intrahepatic cholangiocarcinoma and its clinical significance].
    Lu X; Zhao HT; Sang XT; Mao YL; Chen RR; Zhong SX; Huang JF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Apr; 30(2):197-200. PubMed ID: 18505125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma.
    Sulpice L; Rayar M; Turlin B; Boucher E; Bellaud P; Desille M; Meunier B; Clément B; Boudjema K; Coulouarn C
    J Surg Res; 2014 Nov; 192(1):117-23. PubMed ID: 24909871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highlights of topic "Biochemical and molecular pathological aspects of cholangiocarcinoma".
    Murakami Y
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):359-61. PubMed ID: 24840727
    [No Abstract]   [Full Text] [Related]  

  • 33. Expression of new phenotypic markers in cholangiocarcinoma and putative precursor lesions.
    Roncalli M; Patriarca C; Gambacorta M; Viale G; Coggi G
    J Surg Oncol Suppl; 1993; 3():173-4. PubMed ID: 7684914
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitative analysis of VEGF-C mRNA of extrahepatic cholangiocarcinoma with real-time PCR using samples obtained during endoscopic retrograde cholangiopancreatography.
    Dobashi A; Imazu H; Tatsumi N; Okabe M; Ang TL; Tajiri H
    Scand J Gastroenterol; 2013 Jul; 48(7):848-55. PubMed ID: 23721191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease.
    Klump B; Hsieh CJ; Dette S; Holzmann K; Kiebetalich R; Jung M; Sinn U; Ortner M; Porschen R; Gregor M
    Clin Cancer Res; 2003 May; 9(5):1773-8. PubMed ID: 12738733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescence in situ hybridisation in the cytological diagnosis of pancreatobiliary tumours.
    Boldorini R; Paganotti A; Sartori M; Allegrini S; Miglio U; Orsello M; Veggiani C; Del Piano M; Monga G
    Pathology; 2011 Jun; 43(4):335-9. PubMed ID: 21519286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative proteomic analysis of bile for biomarkers of cholangiocarcinoma.
    Laohaviroj M; Potriquet J; Jia X; Suttiprapa S; Chamgramol Y; Pairojkul C; Sithithaworn P; Mulvenna J; Sripa B
    Tumour Biol; 2017 Jun; 39(6):1010428317705764. PubMed ID: 28618946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overlapping signature genes between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Chen F; Li S; Castranova V
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1320-1. PubMed ID: 19826380
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential membrane proteomics using 18O-labeling to identify biomarkers for cholangiocarcinoma.
    Kristiansen TZ; Harsha HC; Grønborg M; Maitra A; Pandey A
    J Proteome Res; 2008 Nov; 7(11):4670-7. PubMed ID: 18839982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells.
    Wang M; Xiao J; Jiang J; Qin R
    Int J Cancer; 2011 Apr; 128(8):1996-7. PubMed ID: 20568110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.